Asia Pacific Alzheimer's Diagnosis and Treatment Industry - Regional Synopsis
The China Alzheimer’s diagnosis and treatment market, amongst the market in all the other regions, is projected to hold the largest market size of USD 2004.8 million by the end of 2033 by growing at a CAGR of 14.8% over the forecast period. Moreover, the market in the region garnered a revenue of USD 474.0 million in 2022. The growth of the market can be attributed majorly to the increasing cases of Alzheimer’s disease along with rising population of elderly in the region. Tens of millions of families in China are dealing with the life-altering burden of caring for relatives who have Alzheimer's disease as the country's population is ageing quickly. Moreover, over the next 20 years, China's old population is expected to increase by over 100 million, which is causing a sharp rise in dementia cases. In China, there are currently thought to be 10 million Alzheimer's sufferers; by 2050, that number is expected to rise to 40 million.
The Japan Alzheimer’s diagnosis and treatment market, amongst the market in all the other regions, is projected to hold the largest market size of USD 1,723.4 million by the end of 2033 by growing at a CAGR of 15.8% over the forecast period. Moreover, the market in the region garnered a revenue of USD 369.4 million in 2022. The market growth in Japan is attributed to increased cases of dementia in Japan. More than 4.6 million people in Japan are affected by dementia. And it is predicted that as the population ages, this number will increase dramatically.
